The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(19 sites)

United States

Banner University Medical Center, Phoenix, Arizona

UCLA Cardiac Arrthmia Center, Los Angeles, California

University of California San Francisco, San Francisco, California

Medstar Washington Hospital Center, Washington D.C., District of Columbia

Piedmont Heart Institute, Atlanta, Georgia

Emory University, Atlanta, Georgia

Ascension St. Vincent Indianapolis, Indianapolis, Indiana

Univedrsity of Louisville, Louisville, Kentucky

Johns Hopkins University, Baltimore, Maryland

Tufts Medical Center, Boston, Massachusetts

Henry Ford Health, Detroit, Michigan

Columbia University Medical Center, New York, New York

University of Rochester, Rochester, New York

Cleveland Clinic, Cleveland, Ohio

University of Pennsylvania, Philadelphia, Pennsylvania

UPMC, Pittsburgh, Pennsylvania

Medical University of South Carolina, Charleston, South Carolina

Vanderbilt University Medical Center, Nashville, Tennessee

Houston Methodist Hospital, Houston, Texas